| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $8.63, valued at
$17.3k
|
|
| 09/28/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 600 shares
@ $8.71, valued at
$5.2k
|
|
| 08/24/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $9.97, valued at
$10k
|
|
| 08/08/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $10.55, valued at
$21.1k
|
|
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $11.69, valued at
$11.7k
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $12.71, valued at
$3.2k
|
|
| 03/13/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $12.12, valued at
$12.1k
|
|
| 02/28/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $15.395, valued at
$3.8k
|
|
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $18.68, valued at
$18.7k
|
|
| 02/07/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $20.84, valued at
$5.2k
|
|
| 01/31/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $19.35, valued at
$38.7k
|
|
| 01/30/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $19.2, valued at
$4.8k
|
|
| 01/24/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,500 shares
@ $17.37, valued at
$26.1k
|
|
| 01/17/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $16.5, valued at
$4.1k
|
|
| 01/10/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,500 shares
@ $15.18, valued at
$22.8k
|
|
| 01/03/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 4,000 shares
@ $15.19, valued at
$60.8k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 3,000 shares
@ $9.75, valued at
$29.3k
|
|
| 10/11/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $9.72, valued at
$19.4k
|
|
| 10/04/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $9.46, valued at
$9.5k
|
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|